Search Results - "Alhaj Moustafa, Mohamad" :: K.UTB vyhledávací portál

Loading…

Clinical Characteristics, Survival Outcomes, and Prognostic Factors in Primary Cutaneous CD30+ T-Cell Lymphoma: National Cancer Database Analysis (2004-2018)

by Baidoun, Firas, Sluzevich, Jason, Tun, Han W., Alhaj Moustafa, Mohamad
Published in Blood (15.11.2022)

Get full text

Journal Article

Loading…

Clinical Characteristics, Survival Outcomes, and Prognostic Factors in Lymphocyte-Depleted Hodgkin's Lymphoma: National Cancer Database Analysis (2004-2018)

by Baidoun, Firas, Hoppe, Bradford, Tun, Han W., Alhaj Moustafa, Mohamad
Published in Blood (15.11.2022)

Get full text

Journal Article

Loading…

$Therapeutic Outcomes of Relapsed-Refractory Multiple Myeloma Patients with 1q21+Treated with Daratumumab-Based Regimens: A Retrospective Analysis$

Therapeutic Outcomes of Relapsed-Refractory Multiple Myeloma Patients with 1q21+Treated with Daratumumab-Based Regimens: A Retrospective Analysis

by Parrondo, Ricardo D, Gardner, Lindsay Brooke, Alhaj Moustafa, Mohamad, Roy, Vivek, Sher, Taimur, Rasheed, Ahsan, Warsame, Rahma M, Larsen, Jeremy T., Gonsalves, Wilson I., Kourelis, Taxiarchis, Kapoor, Prashant, Fonseca, Rafael, Chanan-Khan, Asher, Ailawadhi, Sikander
Published in Blood (15.11.2022)

Get full text

Journal Article

Clinical Characteristics, Survival Outcomes, and Prognostic Factors in Primary Cutaneous CD30+ T-Cell Lymphoma: National Cancer Database Analysis (2004-2018)

Clinical Characteristics, Survival Outcomes, and Prognostic Factors in Lymphocyte-Depleted Hodgkin's Lymphoma: National Cancer Database Analysis (2004-2018)

Therapeutic Outcomes of Relapsed-Refractory Multiple Myeloma Patients with 1q21+Treated with Daratumumab-Based Regimens: A Retrospective Analysis

Refine Results

Format

Subject Area

Language

Year of Publication

Database